Cargando…
627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials
BACKGROUND: CURE ID is an internet-based data repository (https://cure.ncats.io/explore) developed collaboratively by FDA and NCATS/NIH. It is designed to capture real-world clinical outcome data to advance drug repurposing and to inform future clinical trials for infectious diseases with high unmet...
Autores principales: | Charles, Reema, Paul, Parvesh, Stone, Heather, Gorobet, Serghei, Nhundu, Belinda, Borkowski, Katarzyna M, Duggal, Mili, Tirupathi, Raghavendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644658/ http://dx.doi.org/10.1093/ofid/ofab466.825 |
Ejemplares similares
-
844. Landscape Analysis to Identify Effective Drug Repurposing Candidates for the Treatment of Implantation Mycoses: Comparison of World Health Organization Survey Treatment Data and Published Case Reports on CURE ID
por: Charles, Reema, et al.
Publicado: (2023) -
546. Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19
por: Duggal, Mili, et al.
Publicado: (2020) -
1402. The Landscape of Infections Caused by Rare Bacterial Pathogens
por: Farid, Tahsin, et al.
Publicado: (2023) -
Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium
por: Tirupathi, Raghavendra, et al.
Publicado: (2019) -
Collaborative Use Repurposing Engine (CURE): FDA-NCATS/NIH Effort to Capture the Global Clinical Experience of Drug Repurposing to Facilitate Development of New Treatments for Neglected and Emerging Infectious Diseases
por: Stone, Heather, et al.
Publicado: (2017)